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Comparing Alternative Approaches to
Establishing Regulatory Levels for
Reproductive Toxicants: DBCP As a
Case Study
by William Pease,* John Vandenberg,t and
Kim Hoopert
This paper compares four alternative approaches for deriving regulatory levels for reproductive
toxicants by applying them to the available data on the human spermatotoxicant 1,2-dibromo-3-
chloropropane (DBCP). The alternatives examined include the Proposition 65 approach (application
ofa mandatory 1000-fold uncertainty factor to a no-observed-adverse-effect level [NOAEL]), the En-
vironmental Protection Agency (EPA) approach (application of flexible uncertainty factors to a
NOAEL), the Benchmark Dose approach (application offlexible uncertainty factors to adose associ-
ated with a known level of change in a reproductive parameter), and the Quantitative Risk Estima-
tion approach (using low-dose linear extrapolation and a model of the relationship between sperm
count and infertility).
Applied to DBCP, these approaches do not produce substantially different estimates ofallowable
exposure levels. However, the approaches do have different datarequirements andprovide different
amounts ofinformation onreproductive hazards torisk managers andthepublic. Neither the Propo-
sition 65 nor the EPA approach provides information about the extent ofhealth risk remaining at a
regulatory level. In contrast, the Benchmark Dose approach canprovide estimates ofthe magnitude
of sperm count reduction at a regulatory level, and the Quantitative Risk Estimation approach can
provide estimates of exposure-induced infertility.
Introduction
California's Safe Drinking Water and Toxic Enforce-
ment Act of 1986 (Proposition 65) represents the flrst
generic effort to regulate human exposures to repro-
ductive toxicants. Its passage reflects the widespread
public concernthat environmental exposures may be a
significant and avoidable cause of reproductive or de-
velopmental harm. As of April 1990, 63 substances
were listed as chemicalsknowntothe State to cause re-
productive toxicity. The need to establish regulatory
levels for these substances provides an opportunity to
compare several approaches to calculating acceptable
levels of exposure to reproductive toxicants.
Proposition 65 adopts the conventional regulatory
*Environmental Health Sciences, Warren Hall, School of Public
Health, University of California at Berkeley, Berkeley, CA 94720.
tOffice ofAir Quality Planning and Standards, United States En-
vironmental Protection Agency, Research Triangle Park, NC 27711.
tReproductive and Cancer Hazard Assessment Section, California
Department of Health Services, 2151 Berkeley Way, Berkeley, CA
94704.
Address reprint requests toW. Pease, Warren Hall, School ofPublic
Health, University ofCalifornia at Berkeley, Berkeley, CA 94720.
approach to noncarcinogenic endpoints. A no-observed-
adverse-effect level (NOAEL) for reproductive or de-
velopmental toxicity is identified and divided by an
uncertainty factor(UF)to establish an allowable expo-
surelevel.Believingthatthecommonuseofuncertain-
ty factors of 100 or less did not provide sufficient pro-
tection, supporters ofProposition 65 required the use
of an uncertainty factor of 1000. Due in part to the
perceived inflexibility of this statutory mandate, no
regulatory levels for listed chemicals have been de-
rived using conventional risk assessment methods.
Proposals to amend the reproductive toxicity sections
ofProposition 65 have been debated in the California
Legislature andprovide thepolitical contextfor acom-
parison ofalternative approaches.
Both in California and at the Federal level, regula-
toryagencieshavebeenencouragedtodevelopalterna-
tives to the conventional NOAEL/UF approach to reg-
ulating reproductive and developmental risks (1,2).
The NOAEL/UF approach is limited because it does
not make use of all available dose-response data and
cannotprovide an estimate ofthereproductive risk as-
sociated with a regulatory level. Several reviews ofre-
cent efforts to develop risk estimation procedures forPEASE ET AL.
reproductive and developmental toxicants have been
published (3,4).
The goal of any risk assessment approach is to pro-
vide a scientifically defensible derivation of a regula-
tory level or "reference dose." Following the usage of
the Environmental Protection Agency (5), a reference
dose (RfD)is defined as an estimate ofa daily exposure
to the human population (including sensitive sub-
groups) that is likely tobe without an appreciable risk
of deleterious effects during a lifetime. The RfDs dis-
cussed throughout this paper are based on male repro-
ductive toxicity.
Different approaches to deriving reference doses
have different datarequirementsandprovide different
amounts of information on reproductive hazards to
risk managers and the public. This paper compares
four different approaches to deriving an RfD in an ef-
fort to characterize their strengths and weaknesses.
The four approaches examined are:
a) Proposition 65 approach. Following the require-
ments of Proposition 65 and procedures specified by
the California Health and Welfare Agency, a NOAEL
is identified anddividedby a 1000-fold UF to calculate
an RfD.
b) Environmental Protection Agency (EPA) approach.
Followingthe practice ofEPA, an NOAEL is identified
and divided by a UF that reflects the extent ofuncer-
tainty in the scientific evidence to calculate an RfD.
c) Benchmark Dose approach. As an alternative to
the EPA procedure, the NOAEL is replaced by a
"benchmark dose" (BD), defined as the lower 95% con-
fidence bound on the dose associated with a 10%
change ineffectfromthe control group(6). Tocalculate
an RfD, the BD is divided by a UF that reflects the ex-
tent of uncertainty in the scientific evidence.
d) Quantitative Risk Estimation approach. Follow-
ing procedures analogous to those used in cancer risk
assessment, risks ofan adverse reproductive effect are
calculated using low-dose extrapolation to estimate
the relationship between 1,2-dibromo-3-chloropropane
(DBCP)exposure andspermcountreductionandatwo-
distribution model (7) to predict the relationship be-
tween sperm count reduction and risk of infertility.
Estimates ofmaximumindividual and aggregate popu-
lation risks may be used to establish acceptable levels
ofreproductive risk.
The agricultural nematocide DBCP has been selected
toillustrate theseapproachesbecause oftheavailabili-
ty ofdose-response data and the need to derive a regu-
latory level for this chemical under Proposition 65.
DBCP is a known human reproductive toxicant, caus-
ing decreased sperm counts and increased incidence of
infertility. Under Proposition 65, DBCP has been listed
as a chemical knowntothe State to cause reproductive
toxicity and cancer. After reviewing background in-
formation on DBCP and its toxicology, factors needed
to assess reproductive risk are discussed, regulatory
levels are derived usingthefour approaches, andthese
alternatives are compared.
DBCP: A Case Study
Exposure to DBCP in California
Widespread use of DBCP has resulted in the con-
tamination of a number of aquifers in California (8).
DBCP has been detected in 2113 of5288 wells sampled;
these wells are located in 15 of26 counties surveyed in
California (9). Since the median half-life of DBCP in
groundwater is approximately 20 years (10), DBCP
may persist in California aquifers at detectable levels
for over a century.
Contaminated groundwater is currently the major
source ofexposure to DBCP in California; exposure to
DBCP through food and ambient air has been insig-
nificant since most agricultural use of DBCP was
banned by EPA in 1977. Approximately 200,000 Cali-
fornians are exposed to DBCP in water provided by
large public systems inthe Central Valley; the number
exposed through private wells is unknown. There are
three pathways to be considered in assessing total per-
sonal exposure to DBCP from domestic water: inges-
tionofDBCP-contaminatedwater, inhalation ofDBCP
volatilized into indoor air from daily water use, and
dermal absorption frombathing. About one-third ofan
individual's total DBCP dose is derived from each
pathway (11,12). The average dose per exposed person
ranges between 2 and 4 x 10-5 mg/kg-day (11).
Reproductive Toxicity of DBCP
The adverse effects of DBCP on human testicular
function became widely recognized with the 1977 dis-
covery of azoospermia or severe oligospermia in 14 of
25 male DBCP production workers at an Occidental
Petroleum plant in Lathrop, California (13). These
findings were confirmed by a later extensive study at
the same plant. For the 107 workers who were ever
exposed to DBCP, the median sperm count was 46
million/mL of seminal fluid. For the 35 workers who
were never exposed, the median count was 79 million/
mL ofseminal fluid. Ofthe exposed workers, 13% were
azoospermic, 17% had sperm counts less than 20
millionsperm/mL, and 16% had sperm countsbetween
20 and 39 million sperm/mL. Among the unexposed
workers, 2.9% were azoospermic, none had sperm
counts below 20 million sperm/mL, and 5.7% had
counts between 20 and 39 million sperm/mL. The
estimated duration of exposure was inversely related
to sperm counts (14). Similar adverse reproductive
effects have been reported in other studies of DBCP
production workers (15-17). Figure 1 illustrates the
effect that DBCP exposure had on the distribution of
sperm counts inworkers at aplant inMobile, Alabama
(18).
The consequence ofDBCP's adverse effects on sper-
matogenesis include reduced fertility (subfertility) or
infertility among exposed workers. Couples in which
the male partner was employed at the Lathrop facility
exhibited a standard fertility ratio of0.75 for the peri-
ods when the husband was at risk of DBCP exposure,
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FIGURE 1. Frequency distribution of sperm counts of workers in a
plant in Mobile, Alabama, manufacturing DBCP (7,18).
corresponding to a 25% decrease in fertility (19).
Male exposure to DBCP is also associated with ad-
verse effects on the conceptus. The frequency of spon-
taneous abortions was significantly elevated among
wives offield applicators after their husbands had ex-
posures to DBCP (in banana plantations in Israel),
compared to the frequency of spontaneous abortions
before paternal exposure to DBCP(20). The male-to-fe-
male sex ratio among offspring whose fathers were ex-
posed to DBCP was significantly lower than the ratio
among offspring fathered by unexposed men (21).
There were no congenital abnormalities observed
among children ofworkers who hadreceived sufficient
DBCP exposures to induce oligospermia (22,23). Suffi-
cient studies ofDBCP's developmental effects or repro-
ductive effects on females have not been conducted.
DBCP has multiple targets in the male reproductive
system, including stem cells, epididymal cells, and
postmeiotic cells, and its mechanism ofaction at each
target maywell be different. In humans, spermatogon-
ial stem cells appear to be most susceptible to DBCP
toxicity. Histopathological examination of testicular
biopsies from DBCP-exposed workers revealed degen-
eration ofthe germ cells ofseminiferous tubules, indi-
cating that "suppression of spermatogenesis was re-
lated to a failure ofthe normal process responsible for
the renewal of spermatogonia at the stem-cell level"
(24). The toxicity ofDBCP could be due either to direct
action on the stem cells or to modifications ofenviron-
mental factors critical to the maintenance of stem
cells.
The direct action hypothesis is supported by studies
indicatingthatDBCPtargets cellularDNA, initiating
a process ultimately leading to organ necrosis (25).
DBCP is metabolized by the cytochrome P450 system
or the glutathione conjugation system toform reactive
intermediates that covalently bind to nucleophilic
sites in macromolecules (26,27). Binding of DBCP
metabolites to testicular cell DNA has been demon-
strated (25). Other researchers have postulated that
DBCP maybe selectively cytotoxic to germcells due to
their dependence on aerobic metabolism(28). DBCP is
knowntodisrupt spermcarbohydrate metabolism(29),
and the inhibition of energy processes at the level of
mitochondrialrespirationcouldalso accountforDBCP
toxicity to epididymal sperm (30).
DBCPcouldalso modify hormonal or cellular factors
critical to spermatogenesis, although this hypothesis
is not well supported by available hormonal or histo-
logical data. Hormonal profiles in DBCP-exposed
workers indicate thatstem cells are the likelytarget of
the compound (14,15,18,31-34). Follicle-stimulating
hormone (FSH) levels, a measure ofgerm cell aplasia,
are consistently elevated. Any disruptions of the pi-
tuitary/hypothalamic axis appear to be secondary to
DBCP's effect on the testis (35). Testosterone levels, a
measure of Leydig cell function, were generally nor-
mal, exceptinseverelyaffectedworkerswhoshowedno
signofrecoveryfromDBCPexposure(17,36). This indi-
cates that DBCP does not primarily impact Leydig
cells. Histological examinations of exposed workers
have determinedthat Sertoli cells, the other major cell
type inthetestis, do not appeartobe affectedby DBCP
(24,37,38).
DBCP produces similar adverse reproductive effects
(testicular toxicity, decreased fertility) in a number of
mammalian test species (rats, guinea pigs, and rab-
bits). Reviews ofacute, subchronic, and chronic studies
assessing the reproductive toxicity of DBCP are pro-
vided by Reed et al. (11), the National Academy ofSci-
ences(39), Jackson et al. (40), andBarlow andSullivan
(41). These studies demonstrate a dose-response rela-
tionship between the degree and duration ofexposure
and the severity oftesticular toxicity. The rabbit is the
most sensitive test species (42).
An inhalation dose-response study ofthe gonadotox-
iceffectsofDBCPhasbeenconductedinrabbitsbyRao
et al. (43). Male rabbits(n = 40) were exposed to DBCP
in vapor at 0, 0.1, 1.0, or 10 ppm for 6 hr/day, 5 days/
week for up to 14 weeks. These doses are equivalent to
0, 0.027, 0.27, and 2.7 mg/kg-day, respectively, assum-
ingthat the absorbed fraction ofinhaled DBCP is 50%
(11). This 50% absorption factor is based on animal in-
halation studies of three low-molecular-weight, halo-
genated, aliphatic compounds (44). The time of onset
and extent of decrease in sperm count were dose de-
pendent, and sperm count and viability were signifi-
cantly decreased in a dose-related manner at expo-
sures of 1 ppm DBCP and higher. In the 0.1-ppm dose
group, there was a temporary statistically significant
decrease in sperm count at 12 weeks and an equivocal
increase in sperm with abnormal morphology at 14
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weeks. It is not known whether more substantial
changes would have occurred with exposures longer
than 14 weeks. Exposure at the 10 ppm dose caused
severe atrophy ofthe testes, complete absence ofsper-
matogenesis, and sterility. Exposure in the 10-ppm
dose group was terminated after 8 weeks because of
high mortality.
The effect ofDBCP ingestion on rabbits has been in-
vestigatedinstudiesofshorterduration(45,46),which
may have limited study sensitivity. No evidence ofre-
productive toxicity was reported at a dose level of0.94
mg/kg-day after 10 weeks. In the rabbit inhalation
study, a significant decrease in sperm count in the
1-ppm dose group (absorbing approximately 0.3 mg/kg-
day)was not observed until the end ofweek 11 ofexpo-
sure(43). Inexperiments toidentify malereproductive
toxicants, protocols generally recommend treatment
for a duration equivalent to at least six cycles of the
seminiferous epithelium: 64 days for rabbits (47). The
Rao et al. study(43) indicates that thisperiod is insuf-
ficient to observe the effects of mid-range doses of
DBCP on spermatogenesis, and longer exposures may
be required to examine the effect qfcumulative dam-
age to spermatogonia on sperm counts.
Factors Used to Assess Reproductive
Risks of DBCP
End Point Selection
Several semenparameters serve asbiomarkers ofre-
productive toxicity in males, including sperm concen-
tration, motility and morphology, and the volume and
characteristics of semen. Decrements or changes in
these parameters mayrepresent a decrease infertility
status. Sperm count is a useful indicator of fertility
status, although sperm concentration in the ejaculate
may vary considerablybetween individuals, as well as
across time in an individual. Approximately 10% of
men in the general population are oligospermic, with
sperm concentrations of less than 20 million sperm/
mL semen (48). About 1% of men have essentially no
sperm and are azoospermic. Sperm motility and mor-
phology are less variable in an individual and can also
be usedtoevaluatechanges infertility(49). Arelation-
ship between human male infertility and the propor-
tion ofabnormally shaped orpoorly motile cells in the
ejaculate has been shown (50). In the case of DBCP,
sperm countprovidesthe best measure ofreproductive
toxicity that has been quantitatively ascertained in
humans and animals.
NOAEL Identification and Selection
Althoughthere issufficient evidence inhumansthat
DBCP adversely affects reproductive function in
males,thedose-response datafromtheseepidemiologi-
cal studies are not adequate for risk assessment pur-
poses and cannot be used to determine a human
NOAEL (11,51). Exposure estimates are limited by in-
completeworkplace airmonitoringdataandbytheun-
knowncontributionofdermal absorptiontotheoverall
DBCP exposure. The exposure history ofworkers prior
to DBCP exposure is also unknown. Exposed workers
experienced a range ofadverse effects; data are insuf-
ficienttoassignspecificpercentage decreasesinsperm
counts to particular DBCP dose levels.
Since the data in humans are unreliable, reference
doses for reproductive toxicity are derived using the
inhalation NOAEL for rabbits described in the study
by Rao et al. (43). This study was selected because it
employed the most sensitive test species and was well
conducted. However, variability in the data makes it
difficulttodeterminewhetherthe study actually iden-
tifiedaNOAEL. Inthe 0.1-ppmdose group,both atem-
porary decrease in sperm count and a nonsignificant
increase in the percent of abnormal sperm were ob-
served. After examining the data using different sta-
tistical techniques, we have accepted the conclusion of
Rao et al. thatthe NOAEL was 0.1 ppm underthe con-
ditions of this study. The administered dose corre-
sponding to this NOAEL is 0.054 mg/kg-day, and the
estimated absorbed dose is 0.027 mg/kg-day (11).
The decision to use animal data instead of human
data for risk assessment purposes raises an important
issue. Human males may be more vulnerable to the ef-
fects of reproductive toxicants than other mammals
(52) because the production ofhuman sperm per gram
of tissue is one-fourth that of commonly used labora-
tory animals (53). In addition, the ejaculate offertile
men contains a much higher proportion ofabnormally
shaped sperm than the ejaculate from laboratory ani-
mals (54). Thus, exposures that produce similar (abso-
lute or percent) changes in humans and experimental
animals in either sperm count or frequency of abnor-
mal sperm may decrease male fertility to a greater ex-
tent in humans than in animals.
The decision to select a NOAEL from an inhalation
rather than an ingestion study requires discussion.
There is no direct information on reproductive effects
inhumansresultingfromoral exposurestoDBCP. The
potency of DBCP as a reproductive toxicant may be
influenced by route-specific rates of absorption and
activation/detoxification. In rabbits, the most sensi-
tive experimental species, DBCP was a more potent
spermatotoxicant by inhalationthan by ingestion: the
NOAEL forreproductive effectsfrom DBCPby inhala-
tion was 0.027 mg/kg-day (assuming 50% absorption),
andthe NOAELfrom DBCPby ingestion was 0.94 mg/
kg-day (assuming 100% absorption) (11). This differ-
ence in NOAELs may be due to the difference in expo-
sureperiodortodifferences inthepharmacokineticsof
ingestion and inhalation exposures. Regulatory levels
should be based on the most sensitive study because
pharmacokinetic dataare notavailabletoestimatethe
effective doses that are produced by different routes of
administration, andinhalation aswell as ingestionex-
posures to DBCP occur with contaminated drinking
water.
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Estimating Reference Doses and
Reproductive Risks for DBCP: Four
Alternative Approaches
Proposition 65: Use of a NOAEL and an
Uncertainty Factor of 1000
Procedures for calculating a daily intake level for a
reproductive toxicant are specified in Proposition 65
[California HealthandSafety Code Section25249.10(c)]
and its implementing regulations (Title 22 California
Code ofRegulations Section 12803). An RfD for repro-
ductive toxicity is calculated accordingtothe formula:
RfD = (NOAEL x reference body weight)/1000,
where the NOAEL is determined for the reproductive
effect that formed the basis of the chemical's listing
under Proposition 65. The NOAEL is to be taken from
the most sensitive study deemed to be of sufficient
quality. The referencebodyweightfor an adult male is
70 kg and an uncertainty factor of 1000 is required by
Proposition 65.
Using the NOAEL (0.027 mg/kg-day absorbed dose)
from the rabbit inhalation studyby Rao et al. (43), the
RfD for DBCP calculated using Proposition 65 is
RfD = (0.027 mg/kg-day x 70 kg)/1000
1.9 x 10-3 mg/day, or approximately
2 pg/day
Over69,000 Californians inthe CentralValleyusing
large public water systems as sources of drinking
water receive average daily DBCP doses exceeding 1.9
ig. The maximum daily DBCP exposure experienced
by about 6,000 people is estimated to be 3.0 x 10-4
mg/kg, or about 21 Fg. Estimates ofthe number of ex-
posed persons are likely tobe lowbecause the extent of
DBCP contamination of private wells used for drink-
ing water is unknown (11).
EPA: Use of a NOAEL and an Uncertainty
FactorBased ontheExtentofUncertainty
in Scientific Evidence
State andFederal regulatory agenciescommonly ap-
ply uncertainty factors of 100 or more to animal data
when establishing allowable environmental exposure
levels (55). Generally, State and Federal regulatory
agencies combine several factorsto accountforvarious
sources ofuncertainty in the risk assessment process:
a factor of 10 to reflect variation in sensitivity within
the human population; a factor of 10 to reflect uncer-
tainties in extrapolation from animals to humans; a
factor of 10 to reflect extrapolation from subchronic
studyresults tochronic exposure conditions; afactorof
10 when alowest-observed-adverse-effect level(LOAEL)
is used rather than a NOAEL; and a modifying factor,
rangingfrom greaterthan 0tolessthan orequalto 10,
toreflect other uncertainties inthe studiessuch asthe
number ofspecies tested and the completeness ofthe
overall data base (5,56).
The assignment ofvalues of10 to the factors is arbi-
trary, but data have been developed that lend support
fortheiruse(55,57,58). The minimumuncertaintyfac-
tor used with human data is 10, to account for person-
to-person variability in the population. The minimum
uncertainty factor usedwith animal data is 100, to ac-
countfor the variability in the human population and
fortheuncertaintiesofanimal-to-humanextrapolation.
Selection of uncertainty factors must be made on a
case-by-case examination of a toxicant's biology and
exposure scenario. In the case of DBCP, a judgment
must be made about whether the 14-week period of
exposure employedbyRao et al. (43)constitutes a sub-
chronic orchronic study. Administration ofa test com-
pound over one complete cycle ofthe seminiferous epi-
thelium is recommended in reproductive toxicity
guidelinessothatthepotentialforanagenttoproduce
aneffect atanypoint inthe spermatogenicprocess can
be detected. Depending on a toxicant's mechanism of
action, longer exposures than those recommended
could result in progressive damage and additional ad-
verse effects.
The design ofthe Rao study meets these guidelines:
rabbits were exposed for 98 days, significantly longer
than the 64 days requiredfor a complete cycle ofsemi-
niferous epithelium. However, the study results strong-
ly suggestthat DBCP's effect on sperm count is due to
accumulated damage among stem cells. Reductions in
countonlybecome evident inweeks 8 to 10, indicating
"that DBCP primarily affected spermatogonia" and
not later stages ofsperm development (43). Ifthe Rao
study had been terminated after 10 weeks, satisfying
the guidelines, its NOAEL would have been 1 ppm.
After 14 weeks of exposure, significant sperm count
reductions in the 1-ppm dose group were evident, and
the NOAEL identified was one order of magnitude
lower, 0.1 ppm. The ability ofthe stem cell population
to generate sufficient sperm for successful reproduc-
tion isclearly reducedwith longer exposures to DBCP
inhumans(14). Theprobability ofrecoveryfromDBCP-
associated sperm count reductions is dependent on
cumulative dose. A reasonable explanation for these
observations is that the stem cell population is de-
pleted over time by DBCP toxicity and exhibits de-
creased capacity to repopulate itselfand produce new
sperm.
The relevant human exposure scenario for DBCP in-
volves continuous ingestion, inhalation, and dermal
exposures from the use ofcontaminated groundwater.
Thus, risk assessment must consider cumulative life-
time exposure to DBCP All of the available animal
data are derived from subchronic experiments (10-14
weeks).TheeffectsoflifetimeexposurestoDBCPonre-
productive function have not been studied in animals.
Use of an uncertainty factor to account for the short
duration of the animal study is appropriate because
DBCP's effect on sperm count appears to increase over
time due to the cumulative impact oftoxicity to stem
cells.
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In the case of DBCP, uncertainty factors have been
selected toreflect the quality ofthe data: a 10-fold fac-
tor for intraspecies variability, a 10-fold factor for in-
terspecies extrapolation, a 10-fold factor for use of a
subchronic NOAEL, and amodifyingfactorof1 forrela-
tively high quality data.
Selectionofthesefactorsyields anuncertaintyfactor
of 1000, identical to the uncertainty factor mandated
underProposition 65. Usingthe NOAEL(0.027 mg/kg-
day absorbed dose)fromthe rabbit inhalation study by
Rao et al. (43), the RfD for DBCP derived following
EPA's procedure is 1.9 x 10' mg/day, the same as the
RfD derived using the Proposition 65 approach.
Benchmark Dose: Use of a Benchmark
Dose and an Uncertainty Factor Based on
the Extent of Uncertainty in Scientific
Evidence
Background. The Proposition 65 and EPA ap-
proaches follow conventional regulatory practice by
dividing a NOAEL by factors selected to reflect data
uncertainties to calculate an RfD. Use ofthe NOAEL
as the starting point for deriving an RfD has signifi-
cant limitations (6,59). The NOAEL identified in a
study may be influenced by the sample size in the
study, the selection ofthe dose levels andtheirposition
on the dose-response curve, and the background fre-
quency ofthe end point evaluated (60). Poorer studies
tendtoproducehigherestimatesofthe NOAEL, which
may result in less stringent regulatory levels unless
appropriate uncertainty and modifying factors are
applied.
NOAELsderivedfromstudiesofdifferingdesign and
sensitivity present different residual rates of adverse
health effects. Experimentally determined NOAELs
are clearly not the same as actual no-effect (or thresh-
old) levels for the entire population (6,59,61). A study's
statistical power determines the potential rate of ad-
verse response that may be associated with a no-ob-
served-adverse-effect level. In awell-designed study, as
little as 1% ofthepopulation maybe adversely affected
atthe dose level identified ashaving no effect, whereas
in another, less sensitive study, the residual rate ofad-
verse response at the NOAEL could be as high as 20%
(62).
When the appropriate data are available, the NOAEL
can be replaced by a benchmark dose (BD) to provide a
more uniform basis for the application ofuncertainty
factors. The BD is defined as a statistical, lower confi-
dence limit on a dose producing a predetermined
change in response rate from background. The BD is
calculated from all ofthe dose-response information of
a study rather than from a single point, as is done for
the NOAEL (6). The advantage ofthe BD approach is
that it can provide a starting point for the derivation
ofregulatory levels which represents a known level of
reproductive risk.
Various benchmark levels of effect have been pro-
posed: 1% (63), 5% (64), or 10% (3). These levels have
been recommended because they are easily divided by
uncertainty factors to estimate potential changes in
reproductive parameters at lower dose levels. To pro-
vide a consistent starting point for the assessment of
different compounds, actual experimental data points
have not been selected as BD levels. Extrapolations
from the observed data range to a 1 to 10% effect level
are not particularly sensitive to the choice of mathe-
matical model and do not display the wide variability
in risk estimates produced by different models in low-
dose cancer risk assessment (6).
We have selected 10% as the BD level, following pro-
posed California guidelines for reproductive risk as-
sessment (56) and EPA suggestions (2,3). Given the
need for a standardized approach to reproductive risk
assessment by various regulatory agencies, it makes
sense to use a consensus BD response level.
Table 1. Sperm counts of control and rabbits exposed to
DBCP by inhalation (43).
Millions of sperm/mL of semen, mean ± SD
ppm DBCP
Week ofstudy 0 0.1 1.0 10
Pre-exposure
-2 835 + 237 576 ± 263 630 ± 549 579 + 468
-1 694 + 452 673 ± 416 552 ± 312 546 ± 198
Exposure
1 728 ± 280 494 ± 281 538 + 276 503 ± 255
2 671 + 342 521 + 135 373 ± 244* 347 ± 141
3 657 181 835 ±488 465 ±231 392 ±281 *
4 575 ± 275 618 ± 290 467 ± 126 548 ± 456
5 474 ± 205 391 ± 160 353 ± 186 467 ± 272
6 675 ± 294 576 ± 440 473 ± 165 455 ± 250
7 641 501 531 571 386 251 277 170 *
8a 426 ± 167 423 ± 232 301 ± 167 124 ± 254 *
9 509 255 420 122 510 122 124 275 *
10 473 ± 206 459 ± 284 376 ± 288 7.2 ± 7.0*
11 458 ± 132 360 ± 201 204 ± 131* 5.4 ± 2.0*
12 716 ± 234 382 ± 208* 356 ± 210* 2.4 3.4*
13 758 ± 502 738 ± 376 248 ± 217* 3.7 ± 7.2*
14 602 ± 282 498 ± 499 109 ± 160* 1.9 ± 2.7*
Postexposure
16 604 ± 273 448 ± 157 292 ± 210 0.9 ± 0.8*
19 396 ± 220 500 ± 190 199 ± 221 0.3 ± 0.2*
24 540 ± 560 691 ± 121 532 ± 411 0.4 ± 0.5*
26 452 ± 133 629 ± 115 328 ± 180 1.8 3.5*
27 701 ± 501 415 ± 259 359 ± 189 7.7 ± 10.9*
28 327 ± 213 409 ± 308 542 ± 261 5.1 ± 9.6*
30 728 ± 678 526 ± 244 411 ± 327 4.9 5.9*
32 357 ± 202 628 ± 24* 394 ± 299 6.0 ± 7.0*
34 520 ± 467 535 ± 235 544 ± 301 7.5 ± 11.9*
36 374 ± 197 486 ± 239 471 ± 155 1.7 ± 2.1*
38 667 ± 689 497 ± 196 382 ± 442 39.6 ± 73.0*
40 637 ± 433 616 ± 341 488 ± 544 28.7 ± 44.1*
42 429 ± 284 231 ± 181 559 ± 587 2.0 ± 2.5*
44 497 ± 239 522 ± 196 395 ± 313 8.4 ± 8.6*
46 637 ± 350 583 ± 276 430 ± 107 27.2 ± 37.2*
a Exposures of rabbits to 10 ppm were terminated after 8 weeks
due to toxicity ofthe test material. For the 10-ppm males, the post-
exposure period begins on week 9.
* Significantly different from the control value by Wilcoxon test,
p < 0.05.
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The BD for DBCP was defined as the dose that pro-
duces mean sperm counts in exposed animals that are
10% less than mean sperm counts in control animals
(e.g., for rabbits with mean sperm counts of 600 mil-
lion/mL in the control group, the BD produces mean
sperm counts of540 million/mL inthe exposed group).
To obtain the BD estimate, the lower 95% confidence
limit on the dose corresponding to a 10% decrease in
rabbit sperm count was calculated.
The BD is divided by a UF ofappropriate magnitude
(to reflect the quality ofthe data) to derive the RfD:
RfD = BD/UF
By definingthe BD inthis way(i.e., as a dose produc-
ing decreases in sperm count), it is possible to provide
anestimate ofthe magnitude ofspermcountreduction
at regulatory levels which are derived using different
uncertainty factors, assuming sperm count decreases
linearly with dose at low doses. Exposures at the BD
level, therefore, present quantifiable changes in sperm
count, while exposures at the NOAEL present un-
known risks ofreproductive toxicity.
Calculation of a Reference Dosefor DBCP De-
creased sperm count inthe inhalation study in rabbits
was identified as the most sensitive parameter ofthe
reproductive toxicity ofDBCP(43). The effects ofDBCP
on sperm count in rabbits are presented in Table 1.
Using the approach of Crump (6) and Kimmel and
Gaylor(3), data from the Rao study have been modeled
toestimatethebenchmark doseofDBCPthatwouldbe
associated with a 10% decrease in sperm count. Esti-
mation ofthis dose is not particularly sensitive to the
functional form of model selected, since the effect
levels are close to those experimentally observed. A
linear model was chosen because data on chemothera-
peutic spermatotoxins indicate that spermcounts(log-
arithmically transformed) decrease linearly with in-
creased absorbed dose (65,66). While the mechanism
underlying DBCP's toxicity remains unclear, its activ-
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FIGURE 2. Modeled dose-response curve for DBCP effects on sperm
counts in rabbits exposed by inhalation. Circles represent mean
sperm count (logarithmically transformed) measured in weeks
11 through 14 by Rao et al. (43). Line is model fit.
ity as an alkylating agent and its ability to affect the
DNA of stem cells indicate that a linear model is bio-
logically plausible.
The original data from individual rabbits in the Rao
1982 study were used for the modeling (personal com-
munication, K.S.Rao, 1988). Spermcountswerepooled
for the time at which the effects ofDBCP first became
significant inthe 1-ppm dose group (weeks 11 through
14 ofthe experiment). The high-dose group of 10 ppm
was eliminated from the modeling because DBCP's
systemic toxicity interfered with expression of its
gonadotoxic effects. Halfthe test animals died in the
high-dose group, eventhough exposure was suspended
after only 8 weeks. Modeling conducted on all dose
groups (using logarithmically transformed sperm
counts) indicated that the BD estimate is increased by
only a factor oftwo ifthe high dose group is included.
For each dose group (i) the observed sperm counts
(Yi ) were assumed to follow the lognormal distribu-
tion Yi = eXi, where Xi follows the normal distribution:
Nm(di), a,2]i
The function m(di) represents the mean values of the
log-transformed sperm count data at dose di, and ri2
represents the variance in sperm count at each dose
level.
Using a linear model,
m(di) = a + bdi
where a and b are parameters that are estimated from
the DBCP bioassay data. Maximum likelihood esti-
mates ofthese parameters were calculated under the
constraints that a is positive (i.e., control animals ex-
hibit a positive sperm count) andthat b is less than or
equal to 0(i.e., that exposure toDBCPdecreases sperm
count).
The maximum likelihood estimates of the DBCP
dose-response equation are
m(di) = 6.395 - (4.738)di
The coefficients corresponding to the 95% lower confi-
dence limit are
m(d,) = 6.433 - (7.255)di
The results of this modeling for sperm count are
graphed in Figure 2.
The 95% lower confidence limit on the DBCP dose
associated with a 10% decrease in sperm count from
control values (the benchmark dose) is 0.015 mg/kg-
day. The NOAEL selected from this same rabbit inhal-
ationbioassay (0.027 mg/kg-day)is estimated tobe as-
sociatedwith anapproximately 18% decrease in sperm
count.
AnRfDfor DBCPcanbe establishedby applyingthe
appropriate UF to the BD:
RfD = (0.015 mg/kg-day x 70 kg)/UF
As with the EPA approach, a 1000-fold UF was se-
lected to reflect the quality of the data (i.e., a 10-fold
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factor for intraspecies variability, a 10-fold factor for
interspecies extrapolation, a 10-fold factor for use ofa
subchronic NOAEL, and a modifying factor of 1).
Therefore, the reproductive RfD calculated using the
BD approach is 1.1 Ag/day.
Estimation ofSperm CountDecreaseAssociated
with Exposure toDBCP at theReferenceDose. The
level of sperm count reduction produced by exposures
to DBCP at the RfD level may be estimated using a
techniqueproposedbyKimmelandGaylorforestimat-
inglow-dose developmental toxicity risks(3). The level
ofspermcountreductionfromexposuretoDBCPatthe
RfD level (1.1 itg/day) was calculated by dividing the
levelofreductionpresent attheBDlevelbytheUF. Ex-
posure toDBCPat adosethatis 1000timeslowerthan
the BD (BD/UF = 1000) is associated with a 0.01% de-
crease in sperm count (10% decrease in sperm count/
1000). This procedure assumes that sperm count de-
creases linearly with dose and that there is no thresh-
old in this relationship. These are conservative as-
sumptions and should be interpreted as providing an
upperbound onthe extent ofsperm countreduction at
low doses.
Quantitative RiskEstimation: Use ofLow-
Dose Extrapolation and the Two-
DistributionModeltoEstimateIndividual
and Population Risks of Male Infertility
Background. The BD/UF procedure described
above has one distinct advantage overthe NOAEL/UF
approach: It canbe used toprovide an estimate ofrisk
presentedby exposure to reproductive toxicants at the
RfD level. The BD approach, however, does not make
the estimatebymodelingthe entire doserange. Uncer-
tainty factors are applied subsequent to the modeling
to produce a risk estimate by assuming a linear dose-
response at exposures below the BD.
It is also possible to relate a change in a specific re-
productive parameter (i.e., sperm count) to a function-
ally andsocially relevantendpoint(i.e., male infertili-
ty). Theriskofinfertility in anexposedpopulation can
be estimated by combining our low-dose extrapolation
model ofDBCP's effect on sperm counts with a model
of the relationship between sperm count reductions
and infertility risk. Inthis Quantitative Risk Estima-
tion(QRE)approach, uncertainties in intra- and inter-
speciesextrapolationanddosingregimen areaddressed
during the development of a potency estimate for the
reproductive toxicant.
BoththeBD andQRE approaches sharethe assump-
tion that the relationship between DBCP dose and
sperm count reduction may be approximately linear
over the entire dose range, i.e., that there may be no
threshold for DBCP's effects on sperm count. This as-
sumption, which challenges conventional threshold-
basedapproaches toreproductive risk assessment, can
bejustified in the case ofDBCP onbothbiological and
science policy grounds.
Available data on DBCP are inadequate to resolve
conclusively whether or not there is a threshold for
DBCP's toxic effects on sperm count. The doses which
are associated with the reproductive toxicity ofDBCP
in both occupational and experimental settings are
two orders ofmagnitude higher than current environ-
mental exposures to DBCP in contaminated ground-
water. Hypotheses aboutthe shape ofthe DBCP-sperm-
count dose-response curve in the low-dose region must
be based on a biological model of its mechanism of
action. Some proposed mechanisms of DBCP action
(e.g., inhibition ofepididymal sperm energy processes)
mightexhibitathresholdeffect. However, otherplausi-
blemechanisms ofaction suggest it is inappropriate to
rule out the possibility of low-dose linearity.
Two arguments supportthe biological plausibility of
low-dose linearity for DBCP's effect on sperm count: a)
Ithasbeenpostulatedthat DNAdamage isthe initiat-
ing event in DBCP-induced cell death (67). The repro-
ductive toxicity of DBCP in different animal species
correlateswiththe extentofDNAdamage(25). IfDNA
isthetargetofDBCPtoxicity, itisappropriatetomake
theconservative assumptionoflow-doselinearity, asin
the case ofrisk assessment for carcinogens. b) DBCP
may operate by the same mechanism which is respon-
sible for background rates of decreased sperm count
production. IfDBCP's effects are additive to the risks
from background agents, then its dose-response curve
will be approximately linear in the region of back-
ground incidence (68).
Conventional arguments in support ofthresholds for
noncarcinogenic toxicity may not be applicable to
DBCP. The crux ofmost arguments is that there is an
excess function available in organs, which must be ex-
haustedbeforeclinicallysignificantadverseeffectsare
observed. However, many human males do not have
any excess capacity for sperm production (52,53). The
reversibility ofDBCP's effects on sperm count does not
demonstrate athreshold inthe dose-response curve. In
the case ofDBCP, reversibility is most clearly related
to the exposure scenario. When exposure to DBCP is
stopped, its effects on sperm count are reversible only
if enough stem cells have survived to repopulate the
seminiferous epithelium.
Intheabsence ofanyinformationonthe distribution
of individual thresholds for DBCP toxicity in the hu-
manpopulation, we have assumedthat DBCP reduces
spermcountsovertheentiredoserangeencounteredin
California. This no-threshold assumption is made in
order to produce upper bound estimates ofrisk which
would be useful for risk management purposes. The
same assumption underlies risk estimates produced
usingtheBDapproach(3)andotherproposalstoestab-
lish regulatory levels for noncarcinogenic toxicants
using linear extrapolation (69).
Adoption ofa no-threshold assumption is ultimately
adecisionofsciencepolicy-itisnotdictatedbythetox-
icological data. If the conventional NOAEL/UF ap-
proach isused, the regulatory levels derivedrepresent
unknown risks of reproductive toxicity and an un-
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known proportion ofthe population may have individ-
ual thresholds below the allowable exposure level (61).
If the BD or QRE approaches are used, conservative
estimates ofpotential reproductive risk at regulatory
levels can be derived.
If one makes the plausible assumption that DBCP
can reduce sperm count over the entire dose range,
thenthereshouldbe nothresholdforitseffectonfertil-
ity in anexposedpopulation. There is abroaddistribu-
tion of sperm counts in the human population, which
includes individuals who are severely oligospermic
and at high risk of infertility. Exposure to any agent
which reduces sperm count will shift the distribution
of sperm counts in the population to lower values, in-
creasing the risk of infertility in the population (70).
Reductions in sperm count may cause azoospermia in
highest risk individuals and increase the risk ofinfer-
tility inotherindividuals. Thisrelationshipbetween a
spermatotoxicant and sperm count is illustrated in
Figure 1, which displays two distributions of sperm
counts. The frequency distribution ofsperm counts in
a group ofworkers exposedto DBCP is shifted to lower
values when compared to the distribution ofcounts in
the unexposed cohort. Fewer DBCP-exposed men have
counts above 100 million sperm/mL, and a greater
numberhave countsbelow20 millionsperm/mL, afre-
quently used clinical definition ofinfertility (18).
Risk estimates derived using the health-conserva-
tive assumption that there is no threshold for DBCP's
effects onfertility represent upper bound estimates on
possible risk. Actual infertility risk couldbe zero ifin-
dividuals do have thresholds for DBCP's effect on
sperm count and ifnoindividuals inthe exposedpopu-
lation receive doses greater than their thresholds.
Method. Meistrich and co-workers (7) have devel-
opedamethodwhichcanbeusedtoestimateinfertility
risks for individuals or a population by examining
changes inthe frequency distribution ofsperm counts.
This two-distribution model for reproductive success
(70) can be applied to DBCP to generate estimates of
potential infertility risks in California's Central Valley.
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FIGURE 3. Hypothetical relationship between sperm countreduction
factor and human infertility risk derived by Meistrich and
Brown (7).
Evaluation ofepidemiological data onthe fertility of
1000 men (71) suggests that a 50% reduction in sperm
counts among all members ofa population produced a
4% absolute increase in the rate ofmale infertility in
that population (i.e., infertility increases from an esti-
matedbackground rate of15 to 19%). A 10% reduction
inspermcount inthehumanpopulation willbe associ-
atedwith anabsolute increasedincidence ofinfertility
of about 0.44% (i.e., infertility increases from an esti-
mated background rate of 15 to 15.44%) (7). The rela-
tionshipbetweenspermcountreductionandinfertility
risk is displayed graphically in Figure 3.
Because data on human exposure are inadequate for
modelingpurposes,resultsfromexperimentalanimals
were usedto estimatethe dose that produced a 10% re-
duction in sperm counts. Following the BD approach
described, this dose was estimated to be 0.015 mg/kg-
day in rabbits.
Uncertainties in extrapolation between species, in
intraspecies variation, and in extrapolation from sub-
chronic to chronic exposures were addressed in the
EPA and BD approaches by dividing a NOAEL or BD
byuncertaintyfactors. Someofthese uncertainties are
handled differently inthe QRE approach, as discussed
below.
Interspecies Extrapolation. INTERSPECIES SEN-
SITIVITY TO SPERMATOTOXINS. An interspecies extra-
polation factor (IEF) is needed to estimate the sper-
matotoxic potency of DBCP in humans from animal
data. The IEF is defined (72) as a ratio:
IEF = Dose necessary toproduce a given toxic effect in test animal
Dose necessary to produce the same effect in humans
Reduced sperm count provides a suitable end point on
which to base the determination ofthe IEF because it
is quantifiable in experimental animals and in man.
Interspeciesvariability inresponse to DBCPwas ad-
dressed by assuming that humans could either be
equallyormore sensitivethananimalsandbydevelop-
ingpotency estimatesaccordingly. The lowestimate of
an IEF for DBCP is 1, indicating that the sensitivity
ofhumans andrabbits are equal(Fig. 4). DBCP's alky-
lating activity and disruption of sperm metabolism
suggest that its mechanism of action in lowering
sperm count may be similar in animals and man (11).
Selection ofan IEF of1 is supported by a limited com-
parison of high-dose animal and human response to
DBCP exposure. The experimental dose (0.27 mg/kg-
day absorbed) that produced substantial reductions in
rabbit sperm count (> 50% decrease after 14 weeks of
exposure)anddecreasedfertility(30% decrease intotal
implantations per litter) was similar to the minimum
doseestimatefromoccupational exposure(0.19mg/kg-
day absorbed)that produced substantial reductions in
sperm counts andfertility in humans. Human adverse
effects and dose levels were not sufficiently quantified
to allow a direct calculation of a ratio of species sen-
sitivity.
The high estimate of an IEF for DBCP (Fig. 4) as-
sumes humans are more sensitive than rabbits. This
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FIGURE 4. Modeled low-dose relationship between DBCP exposure
atenvironmental levels and sperm count reduction. (IEF = 1 and
IEF = 60).
estimate incorporates available data on differences in
susceptibility and pharmacokinetics. Studies on the
differential susceptibility ofmen andmice tothe effect
ofradiation on spermatogenesis provide the only data
available on interspecies sensitivity in which tissue
doses are known to be the same. Similar data are not
available forrabbits. Inradiation exposure studies, the
IEF ranges from 11 to 21 when measured atthe end of
the interval necessary for stem cells to become sperm
(i.e., at 115daysin menandat56daysinmice). TheIEF
ranges from 20 to 44 when measured at the time when
ejaculate sperm counts reach a minimum (i.e., at 35
weeks in men and at 18 weeks in mice) (73). These
values indicate humans are more sensitive than ex-
perimental animals to the effects ofionizing radiation
on stem cells. For chemical spermatotoxicants, data
comparinginterspecies sensitivity are sparse. A factor
of20 was selected from the data reviewed by Meistrich
(71)toobtain an estimate ofthe potential sensitivity of
human stem cells.
INTERSPECIES DIFFERENCES IN METABOLISM AND
DISTRIBUTION. Administered doses are used to esti-
mate the IEF, but they may not reflect the doses to the
target organ (the testes in the case of DBCP) in dif-
ferent species. Such differences can be corrected for by
the application ofthe default interspecies scaling pro-
cedure employed in cancer risk assessment, in which
milligram per unit surface area is an equivalent mea-
sure ofdose in different species (68,74). Scaling to the
estimated human potency is obtained by multiplying
the animal potency by the ratio of human to animal
body weights raised to the one-third power. For 2-kg
rabbits this interspecies correction factor is (70/2)1/3 =
3. An adverse effect dose in rabbits is divided by a fac-
tor of 3 to estimate a similar adverse effect dose for
humans. The same scaling can be obtainedby convert-
ing administered doses from milligrams per kilogram
tomilligrams per square meter andthen deriving a po-
tency estimate, as was done by Meistrich (7) in a simi-
lar analysis.
HIGH ESTIMATE OF THE IEF. Multiplying the avail-
able estimate ofinterspecies differences in sensitivity
(a factor of20)by the estimated differences inpharma-
cokinetics(afactorof3)produces ahighestimate ofthe
IEF of60. The dose producing a 10% change in rabbit
sperm count is divided by 60 to estimate the dose pro-
ducing a 10% change inhuman sperm count(Fig. 4). At
anIEF of1, there is only a minimal reductionofsperm
count overthe rangeofenvironmental exposureslikely
in California. At an IEF of60, there is a 14% reduction
in sperm count over this same range.
Intraspecies Variability. Intrahuman variability
in susceptibility to the effect of sperm count reduction
on fertility is incorporated into the two-distribution
model. The relationship between reductions in sperm
countandmale infertilityrisk wasderived(7,70)using
data from 1000 men (71), providing an adequate mea-
sure of the distribution of susceptibility in a popula-
tion. Intrahuman variability in susceptibility to
DBCP's effect on sperm count is not explicitly ad-
dressed because ofthe absence of data. Uncertainties
surroundingbothofthese sourcesofintraspeciesvaria-
bility are addressed by the use ofa 10-fold uncertainty
factor in the conventional NOAEL/UF approach.
Subchronic versus ChronicExposures. The DBCP
dose-response modeling is based on a rabbit study of
less-than-lifetime duration. Inthe NOAELandBD ap-
proaches, this limitation in the animal data was ac-
counted for by application of a 10-fold uncertainty fac-
tor. In the QRE approach, no explicit adjustment for
the subchronic duration ofthe rabbit study was made.
As indicated by the interspecies comparison ofthe ef-
fectsofradiation, thetime atwhichdamageisassessed
influences the magnitude ofthe IEF: the IEF will be
highifeffects are assessedshortlyafter acute exposure
or during chronic exposure, and will approach unity if
effects are assessed when recovery has occurred after
cessation of exposure (72).
Calculation ofDBCPPotencyEstimates. Low and
high estimates of DBCP's potency are derived using
the range ofpossible IEFs. The low estimate (IEF = 1)
uses the potency derived from rabbit data (1.5 x 10'2
mg/kg-day)/(10% decrease in sperm count) as the hu-
man potency. A dose of 1.5 x 102 mg/kg-day reduces
sperm count 10% and is estimated to produce a 0.44%
absolute increase in infertility in an exposed popula-
tion. Assuming linearity in the low-dose range, a
DBCP dose of 3.4 x 102 mg/kg-day is estimated to
produce anincrease of1% in infertility above the back-
ground rate in an exposed population.
Tocalculate ahighestimate(IEF = 60),therabbit po-
tency was divided by the interspecies scaling factor of
20 and the pharmacokinetics factor of3 to produce an
estimate of the DBCP potency for humans of (2.5 x
10-4 mg/kg-day)/(10% decrease in sperm count). A
dose of 2.5 x 10-4 mg/kg-day reduces sperm count
10% and is estimated to produce a 0.44% absolute in-
crease in infertility in an exposed population. Assum-
ing linearity in the low-dose range, a DBCP dose of5.7
X 10-4 mg/kg-day is estimated to produce an increase
IEF=60
IEF=1
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of 1% in infertility above the background rate in an
exposed population.
MaximumIndividualRisk ofInfertility. The max-
imum DBCPdose delivered to a person drinking water
from a large public water system in the Central Valley
is 3.0 x 10' mg/kg-day (11). The low and high esti-
mates ofthe maximum individual risk (MIR) ofinfer-
tility are:
Low Estimate MIR = 3.0 x 104 mg/kg-day
(3.4 x 10' mg/kg-day)/(1% increased risk)
= 8.8 x 10-5 or approximately a 9 in 100,000
increased risk of infertility.
High Estimate MIR = 3.0 x 10-4 mg/kg-day
(5.7 x 10-4 mg/kg-day)/(1% increased risk)
= 5.37 x 10-3 or approximately a 500 in
100,000 increased risk of infertility.
The range of infertility risks arising from potential
environmental exposures in the Central Valley is
graphed in Figure 5. The infertility risk presented by
DBCP exposure in private well water could be consid-
erably higher. There are no data available on the mag-
nitude of these exposures. These risk estimates are
based on the health-conservative assumption that
DBCP affects sperm count over the entire dose range
experienced in the Central Valley. Actual risks could
be zero ifindividuals do have thresholds for DBCP's ef-
fect on sperm count andifno individuals inthe exposed
population receive doses greaterthantheirthresholds.
Aggregate Population Risk ofInfertility. The ag-
gregate population risk of increased infertility result-
ing from DBCP exposure in the Central Valley ofCali-
fornia is estimated by combiningthe low andhigh esti-
mates ofDBCP potency with information onthe extent
of human exposures to DBCP The doses from inges-
tion, inhalation, and dermal absorption of DBCP re-
sulting from household use of contaminated water
from public water systems are presented in Table 2.
Estimates were made ofthe size ofthe population ex-
posed to various doses (ranging from 2.5 x 10-6 to 3.0
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FIGURE 5. Estimated low-dose relationship between DBCP exposure
at environmental levels and human infertility risk (IEF = 1 and
IEF = 60).
Table 2. DBCP well water risk assessment: exposure from
large public water systems in California's CentralValley (11).
Average
DBCP dose Number of
per person, exposed Risk per group
mg/kg-day persons IEF = 1 IEF = 60
2.5 x 10-6 83465 0.03 1.9
7.0 x 10-6 28093 0.03 1.8
1.2 x 10-5 18907 0.03 2.1
1.6 x 10-5 4506 0.01 0.7
2.2 x 10-5 6638 0.02 1.3
2.7 x 10-5 8687 0.03 2.1
3.2 x 10-5 3679 0.02 1.1
3.7 x 10-5 4448 0.02 1.5
4.0 x 10-5 3722 0.02 1.3
4.4 x 10-" 2377 0.02 0.9
4.9 x 10-' 3674 0.03 1.6
5.4 x 10-5 2782 0.02 1.3
5.9 x 10-5 5418 0.05 2.9
6.5 x 10-s 5522 0.05 3.2
6.9 x 10-5 587 0.01 0.4
7.4 x 10-5 2855 0.03 1.9
8.1 x 10-5 3255 0.04 2.3
8.3 x 10-5 2339 0.03 1.7
8.8 x 10-5 2230 0.03 1.7
1.0 X 10-4 2339 0.04 2.1
1.1 x 10-4 2339 0.04 2.3
1.2 x 10-4 5420 0.09 5.6
1.2 x 10-4 1581 0.03 1.7
1.3 x 10-4 1700 0.03 2.0
1.4 x 10-4 1700 0.03 2.1
1.7 x 10-4 4275 0.11 6.5
1.8 x 10-4 732 0.02 1.2
3.0 x 10-4 6386 0.29 17.3
Total number ofexcess 1 70
cases of male infertility
x 10- mg/kg-day) ofDBCP in contaminated drinking
water(11).Assumingthatthedose-response waslinear
overthisrange andthathalfoftheexposedindividuals
weremales,thepotential minimum(IEF = 1)andmax-
imum (IEF = 60) aggregate risks to the exposed popu-
lation were calculated (Table 2). ,
The aggregate additional incidence ofmale infertili-
ty ranges between 1 and 70 cases. Infertility is defined
as the number ofcouples trying and failing to achieve
pregnancyforatleast 1 year(7). Incidenceestimatesdo
not mean that the couples are permanently infertile,
but that the time to pregnancy may be increased or
pregnancy may not be achieved. A study ofbirth rates
in Fresno County, CA, revealed no effects on fertility
fromexposurestoDBCP-contaminateddrinkingwater
(75). Given the small number of infertility cases pre-
dictedby eventhe most conservative modelingandthe
limited sensitivity (76) ofthe measure used to assess
fertility in this study (standardized birth ratio), these
negative findings are not surprising.
Comparison of Reference Doses and
Risk Estimates for DBCP Derived by
the Four Alternative Approaches
The reference dosesfor reproductive toxicity derived
for DBCP by the Proposition 65, EPA, and BD proce-
dures are similar, although a slightly lower RfD was
IEF=60/
IEF=l-1
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Table 3. Regulatory levels and risk information obtainable
from four approaches to reproductive risk assessment.
Level of sperm Risk of
Regulatory count reduction infertility
Approach level RfDa at RfD at RfD
Proposition 65 1.9 iLg/d Not obtainable Not obtainable
EPA 1.9 Ag/d Not obtainable Not obtainable
Benchmark dose 1.1 ag/d 0.01% Obtainable if
association
between
reproductive
biomarker and
infertility
is known
Quantitative Need to set Obtainable Obtainable
risk assessment acceptable for all for all
risk level dose levels dose levels
a RfD, reference dose.
derivedusing aBDratherthan aNOAEL. The similar-
ity ofthese RfD estimates does not prove that the RfD
is valid; it only indicates that working from the same
data set, alternative approaches produce similar regu-
latory levels. In the case of DBCP, alternative ap-
proaches do provide additional information on the
magnitude and extent of reproductive risks that can
improve both risk management and risk communica-
tion. Table 3 shows the regulatory levels derived using
alternative approaches and describes the additional
risk information which can be obtained from each.
Both the Proposition 65 approach and the EPA ap-
proach are based on establishing a NOAEL and divid-
ing by conventional but arbitrary uncertainty factors.
Neither approach provides information about the ex-
tent ofhealth risk remaining at a regulatory level. In
contrast, the BD approach uses all available dose-re-
sponse data and associates the RfD level with a risk
estimate. This approach establishes a more consistent
startingpointfortheapplication ofuncertaintyfactors
and provides potentially important risk information.
The BD risk estimates, however, will generally de-
scribe a change in a reproductive parameter and not a
change in asocially meaningful endpoint. The BD pro-
cedure can be applied to dose-response data for a vari-
ety of sensitive end points assessed in reproductive
toxicity assays, but the significance ofsmall projected
alterations in these parameters (e.g., diameter ofsemi-
niferoustubules)isunclear. Onlywhenthe association
between a change in a reproductive biomarker and re-
productive function is known (as is the case for sperm
count reduction and infertility risk) can predictions of
socially meaningful risk be made. An additional dis-
advantage of the BD procedure is its combination of
dose-response modeling and arbitrary uncertainty fac-
tors. To provide an upper bound estimate of risk, the
procedure assumes risk decreases linearly with dose
from the BD estimate. This conservative assumption
does notuse the actual slope ofthe dose-response curve
(derived from the experimental data) to estimate low-
dose risks.
The QRE approach uses the same dose-response
model of animal data as in the BD approach, but ex-
tends the model to estimate levels of sperm count re-
duction and risks ofinfertility in the low-dose region.
Risks may be estimated for any point along the dose-
response curve. Some ofthe uncertainties that are ad-
dressed with conventional 10-fold uncertainty factors
can be quantitatively addressed in the development of
a potency estimate in the QRE approach (e.g., varia-
tions in interspecies susceptibility and pharmacokin-
etics). Otheruncertainties aremoredifficulttoaddress
inthe QRE approach(e.g., subchronicto chronic expos-
ure extrapolation), at least with the available DBCP
data.
The QRE approachcanbe usedto assesstheresidual
reproductive risk associatedwithregulatory levels de-
rived using uncertainty-factor-based approaches. At
1.9Ag/day,the RfD derivedusingthe Proposition 65 or
EPA approach, the maximum estimated risk of
infertility from DBCP exposures is 4.8 x 10-4. At 1.1
pLg/day, the Rfd derived using the BD approach, the
maximum estimated risk of infertility from DBCP
exposures is 2.8 x 104.
The QRE approach also provides conservative esti-
mates of the aggregate population incidence of male
infertility produced by exposures to DBCP (Table 2).
Since the contribution ofvarious sectors ofthe popula-
tion to total incidence can be quantified, the impact of
regulatory decisions onthe reduction ofthe number of
excess cases ofmale infertility in the exposed popula-
tion canbe evaluated. Estimates ofmaximum individ-
ual risk and population incidence of reproductive ef-
fects are similar inconcepttothose produced in cancer
risk assessment. Information about the magnitude of
individual risks and the extent of population effects
canbe usedto improve communicationwiththepublic
about the relative importance ofvarious reproductive
hazards.
The QRE approach has several disadvantages as an
alternative procedure for reproductive risk assess-
ment. The approach canbe usedto derive aregulatory
level only ifa policy decision is made about an accept-
able level ofreproductive risk. But to reach social con-
sensus on acceptable risk levels, some common unit of
risk that is socially meaningful is required (compar-
able totheone-in-a-million lifetime cancerriskusedin
cancer risk assessment). Application of the QRE ap-
proach will be restricted to compounds that affect bio-
logicalparameterswithquantifiable impacts onrepro-
ductive success. DBCPisjust oneexample ofa number
of compounds where sufficient data are available to
link experimentally observed end points (reduction in
sperm count) with socially significant outcomes (in-
creased infertility in a population). Wyrobek et al. (77)
catalogued 52 chemical exposures that have been re-
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portedto leadto reduced spermproduction inhumans.
The QRE approach warrants further evaluation with
these agents, especially in situations that are amen-
able to epidemiological analyses ofchanges infertility
and reproductive outcome.
Models that attempt to estimate low-dose risks from
exposures to reproductive toxicants challenge the tra-
ditional assumptions ofreproductive risk assessment.
The NOAEL/UF approach assumes there is a thresh-
old exposure level below which no toxic effects occur,
and that individuals incur a reproductive risk only if
their level ofexposure to an agent exceeds their indi-
vidualthresholdlevel. Duetostatisticallimitations on
identifying a NOAEL, it canbe expected in some cases
that a significant proportion of the population will
have individual thresholds that are below the accept-
able exposure level established by the NOAEL/UF
approach (61).
The linear model used inthe BD andQRE approach-
esdoesnotassumethatthere is athresholdforDBCP's
toxic effects on spermatagonial stem cells or its effect
on infertility in an exposed population. It isbiological-
ly plausible that stem cell loss may be linear at low
doses ofDBCP Ifsperm counts are reduced, there will
be no threshold for DBCP's effect on infertility risk.
These assumptions are made in ordertoproduce upper
bound estimates ofrisk which would be useful for risk
management and communication purposes. Usingthe
QRE approach, reproductive risk assessment for some
compounds becomes similar to cancer risk assessment
and poses a fundamental question that the conven-
tional NOAEL/UF approach ignores: What level of
estimated reproductive risk is acceptable?
The selection ofapreferred approach depends onthe
understanding ofthe toxicology ofa substance and its
effects onthepopulation distribution ofareproductive
end point as well as on a regulatory agency's legal
mandate. Few precedents for regulatory decisions on
reproductive or developmental toxicants are available
at the State orFederal level, with California's Proposi-
tion 65 currently prominent for its emphasis on repro-
ductive toxicity as well as cancer. The comparison of
alternative approaches to deriving reference doses for
reproductive toxicants provided in this risk assess-
ment ofDBCPclarifies what information and assump-
tions arerequired toreplacethe conventional NOAEL/
UF approach.
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